Primary care in the treatment of functional gastrointestinal symptoms in Japan: prescription preferences and impression of results

被引:7
作者
Hongo, M
Kanatsuka, H
Sugawara, A
Nagasaki, Y
Endo, Y
Karahashi, K
Shoji, T
Sagami, Y
Aoki, I
机构
[1] Tohoku Univ, Dept Comprehens Med, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Dept Psychosomat Med, Sendai, Miyagi 9808574, Japan
关键词
D O I
10.1111/j.1365-2036.2005.02474.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Functional gastrointestinal (GI) disorders are common in primary care. However, proper pharmacological approaches have not yet been established. The reason for a lack of proper approaches may be attributable to the lack in clarity of their pathogenesis and pathophysiology. Meta-analysis of pharmacological approaches to functional GI disorders failed to identify the solid cluster of patients' symptoms. Aim: The aim of this study is to assess the perspective of primary care doctors concerning prescriptions for functional GI symptoms, evaluate the efficacy of the drugs prescribed, and the need for medication for these symptoms. Method: Ouestionnaires were sent to primary care doctors, and a total of 149 responses were obtained. Efficacy of each medication was evaluated by the number of doctors favouring the category, and the respective impressions of prescriptions given. Results: Symptoms of heartburn were well controlled by anti-secretory drugs (H2RAs and PPIs), while appetite loss and abdominal gurgling were not controlled by any medications. Conclusions: This survey reveals differences in need for various prescription drugs in functional GI symptoms.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 23 条
[1]  
[Anonymous], COCHRANE DB SYST REV
[2]   Are dyspepsia management guidelines coherent with primary care practice? [J].
Cardin, F ;
Zorzi, M ;
Furlanetto, A ;
Guerra, C ;
Bandini, F ;
Polito, D ;
Bano, F ;
Grion, AM ;
Toffanin, R .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (11) :1269-1275
[3]   Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis [J].
Chiba, N ;
DeGara, CJ ;
Wilkinson, JM ;
Hunt, RH .
GASTROENTEROLOGY, 1997, 112 (06) :1798-1810
[4]   GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE [J].
DEVAULT, KR ;
CASTELL, DO .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (20) :2165-2173
[5]   Quality of life in patients with upper gastrointestinal symptoms: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST) [J].
Enck, P ;
Dubois, D ;
Marquis, P .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 :48-54
[6]   Symptom-based outcome measures for dyspepsia and GERD trials: A systematic review [J].
Fraser, A ;
Delaney, B ;
Moayyedi, P .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (02) :442-452
[7]   Quality of life: A reflection of symptoms and concerns [J].
Glise, H ;
Hallerback, B ;
Wiklund, I .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 :14-17
[8]   The health economic impact of upper gastrointestinal symptoms in the general population: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST) [J].
Haycox, A ;
Einarson, T ;
Eggleston, A .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 :38-47
[9]  
HONGO M, 1999, PROGR MED, V19, P2024
[10]   Guidelines for dyspepsia treatment in Japan [J].
Matsueda, K .
CLINICAL THERAPEUTICS, 1998, 20 :D13-D21